Team lead for commercial strategy and forecasting for global biotech/ pharma clients in multiple therapeutic areas:• Characterized buying process of rare neurological disorder and built forecast model for a global pharma/ biotech company• Developed strategy to improve utilization of genetic testing and decrease time to diagnosis of ultra-rare genetic diseases in advance of product launch• Quantitatively measured impact of physician advertising campaign on referral rates of NSCLC• Characterized patient journey of a rare hematological disorder to develop patient services for a mid-cap biotech• Developed forecast for anti-sense oligonucleotide therapeutic to treat rare neurological disorder by conducting quantitative and qualitative market research with physicians and patients

Provide consulting services to startup, non-profit, and biotech/ pharma firms:• Driving design and implementation of a set of prizes including wet-lab and bioinformatics challenges to stimulate the development of a cure for NGLY1 deficiency • Conducted due diligence and prior art search for university licensing of small molecule indicated for wound healing• Drove pre-launch implementation of hospital sales strategy for a specialty pharma asset

Project lead for commercial and medical affairs strategy for global biotech/ pharma clients in multiple therapeutic areas:• Characterized the buying process and patient journey in several countries for an ultra rare disease to prepare for upcoming launch efforts • Evaluated partnering opportunities for a novel cell-based oncology therapeutic• Designed a customer-centric engagement strategy across oncology and other therapeutic areas for the medical affairs group of an international pharmaceutical company • Directed the establishment of a global scorecard to track market performance of an infused oncolytic • Led US brand planning efforts for a new oral treatment for idiopathic pulmonary fibrosis • Developed medical affairs operating procedures for collaboration between diagnostic and therapeutic divisions for the launch of companion diagnostics• Investigated dry eye treatment landscape to develop brand strategy for a medical device – company acquired 2 months after project completion• Synchronized and aligned demand and supply reconciliation for the oncology supply chain of an international pharmaceutical company leading to 50% reduction in employee time for creation of forecasts• Led operational benchmarking research and strategic partnering initiatives for the medical and scientific affairs group of a biotech company specializing in oncology therapeutics